RGD Reference Report - Loss of NF2/Merlin expression in advanced sporadic colorectal cancer. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Loss of NF2/Merlin expression in advanced sporadic colorectal cancer.

Authors: Cačev, Tamara  Aralica, Gorana  Lončar, Božo  Kapitanović, Sanja 
Citation: Cačev T, etal., Cell Oncol (Dordr). 2014 Feb;37(1):69-77. doi: 10.1007/s13402-013-0164-2. Epub 2013 Dec 10.
RGD ID: 150530506
Pubmed: PMID:24323642   (View Abstract at PubMed)
DOI: DOI:10.1007/s13402-013-0164-2   (Journal Full-text)


PURPOSE: NF2/Merlin was first identified through its association with neurofibromatosis type 2 (NF2). However, accumulating evidence suggests a more general involvement in tumorigenesis and, in particular, a broader role in tumor suppression. The aim of this study was to examine NF2/Merlin involvement in sporadic colorectal cancer.
METHODS: This study is the first to examine the role of NF2/Merlin in sporadic colorectal cancer through LOH analysis at the NF2 locus and mRNA expression analysis via quantitative RT-PCR of total NF2, NF2 isoform I and II. In addition, Merlin protein expression was assessed by immunohistochemistry and Western blotting.
RESULTS: NF2 LOH was detected in 20.0 % of heterozygous cases and was found to be more frequent in tumors larger than 5 cm in diameter (p = 0.041) and in tumors with a less differentiated phenotype (p = 0.027). No differences were observed in total NF2 and NF2 isoform I/isoform II mRNA expression between the tumors and their corresponding normal mucous tissues. NF2 isoform II was the most predominant isoform in all samples analyzed. mRNA expression levels of total NF2 and isoforms I and II were significantly lower in poorly differentiated tumors (p = 0.033, p = 0.036 and p = 0.044, respectively). Weak Merlin immunostaining was more frequent in poorly differentiated tumors (p = 0.034) and tumors classified as Dukes' C (p = 0.023). A distinct pattern of Merin phosphorylation was observed in tumors compared to normal mucous tissues.
CONCLUSION: Our data indicate that NF2/Merlin may serve as a potential target in the management of colorectal cancer.

RGD Manual Disease Annotations    Click to see Annotation Detail View
TermQualifierEvidenceWithReferenceNotesSourceOriginal Reference(s)
colorectal cancer  IAGP 150530506DNA:loss of heterozygosityRGD 
colorectal cancer  ISONF2 (Homo sapiens)150530506; 150530506DNA:loss of heterozygosityRGD 

Objects Annotated

Genes (Rattus norvegicus)
Nf2  (NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor)

Genes (Mus musculus)
Nf2  (neurofibromin 2)

Genes (Homo sapiens)
NF2  (NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor)


Additional Information